Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283012017> ?p ?o ?g. }
- W4283012017 abstract "Cellular immunotherapies based on T cell receptor (TCR) transfer are promising approaches for the treatment of cancer and chronic viral infections. The discovery of novel receptors is expanding considerably; however, the clinical development of TCR-T cell therapies still lags. Here we provide a pipeline for process development and clinical-scale manufacturing of TCR-T cells in academia. We utilized two TCRs specific for hepatitis C virus (HCV) as models because of their marked differences in avidity and functional profile in TCR-redirected cells. With our clinical-scale pipeline, we reproduced the functional profile associated with each TCR. Moreover, the two TCR-T cell products demonstrated similar yield, purity, transduction efficiency as well as phenotype. The TCR-T cell products had a highly reproducible yield of over 1.4 × 10 9 cells, with an average viability of 93%; 97.8–99% of cells were CD3+, of which 47.66 ± 2.02% were CD8+ T cells; the phenotype was markedly associated with central memory (CD62L+CD45RO+) for CD4+ (93.70 ± 5.23%) and CD8+ (94.26 ± 4.04%). The functional assessments in 2D and 3D cell culture assays showed that TCR-T cells mounted a polyfunctional response to the cognate HCV peptide target in tumor cell lines, including killing. Collectively, we report a solid strategy for the efficient large-scale manufacturing of TCR-T cells." @default.
- W4283012017 created "2022-06-18" @default.
- W4283012017 creator A5008579041 @default.
- W4283012017 creator A5016740410 @default.
- W4283012017 creator A5019440530 @default.
- W4283012017 creator A5020405049 @default.
- W4283012017 creator A5021835847 @default.
- W4283012017 creator A5033369669 @default.
- W4283012017 creator A5033991846 @default.
- W4283012017 creator A5035328333 @default.
- W4283012017 creator A5056333353 @default.
- W4283012017 creator A5057116894 @default.
- W4283012017 creator A5058478410 @default.
- W4283012017 creator A5058665443 @default.
- W4283012017 creator A5059343991 @default.
- W4283012017 creator A5081241413 @default.
- W4283012017 date "2022-06-16" @default.
- W4283012017 modified "2023-10-16" @default.
- W4283012017 title "Process Development for Adoptive Cell Therapy in Academia: A Pipeline for Clinical-Scale Manufacturing of Multiple TCR-T Cell Products" @default.
- W4283012017 cites W1964287019 @default.
- W4283012017 cites W1988754108 @default.
- W4283012017 cites W2000734326 @default.
- W4283012017 cites W2018968534 @default.
- W4283012017 cites W2021122662 @default.
- W4283012017 cites W2022330759 @default.
- W4283012017 cites W2036836249 @default.
- W4283012017 cites W2047192675 @default.
- W4283012017 cites W2071911570 @default.
- W4283012017 cites W2072666173 @default.
- W4283012017 cites W2077200917 @default.
- W4283012017 cites W2111359040 @default.
- W4283012017 cites W2114229735 @default.
- W4283012017 cites W2116928202 @default.
- W4283012017 cites W2118796952 @default.
- W4283012017 cites W2119695991 @default.
- W4283012017 cites W2126500343 @default.
- W4283012017 cites W2131907571 @default.
- W4283012017 cites W2137929296 @default.
- W4283012017 cites W2142555989 @default.
- W4283012017 cites W2149164390 @default.
- W4283012017 cites W2157034871 @default.
- W4283012017 cites W2167550136 @default.
- W4283012017 cites W2170513194 @default.
- W4283012017 cites W2171082742 @default.
- W4283012017 cites W2415719708 @default.
- W4283012017 cites W2443085751 @default.
- W4283012017 cites W2470125153 @default.
- W4283012017 cites W2547569411 @default.
- W4283012017 cites W2557064805 @default.
- W4283012017 cites W2558551486 @default.
- W4283012017 cites W2566490479 @default.
- W4283012017 cites W2589184953 @default.
- W4283012017 cites W2613659662 @default.
- W4283012017 cites W2761560083 @default.
- W4283012017 cites W2799945527 @default.
- W4283012017 cites W2895040177 @default.
- W4283012017 cites W2896297455 @default.
- W4283012017 cites W2908759880 @default.
- W4283012017 cites W2913558101 @default.
- W4283012017 cites W2966041852 @default.
- W4283012017 cites W2966895087 @default.
- W4283012017 cites W2979872362 @default.
- W4283012017 cites W3003461312 @default.
- W4283012017 cites W3015507915 @default.
- W4283012017 cites W3016233874 @default.
- W4283012017 cites W3048276742 @default.
- W4283012017 cites W3089727781 @default.
- W4283012017 cites W3095506675 @default.
- W4283012017 cites W3096010551 @default.
- W4283012017 cites W3110018523 @default.
- W4283012017 cites W3116401648 @default.
- W4283012017 cites W3117758135 @default.
- W4283012017 cites W3119907614 @default.
- W4283012017 cites W3126515851 @default.
- W4283012017 cites W3137400352 @default.
- W4283012017 cites W3154219297 @default.
- W4283012017 cites W3176875021 @default.
- W4283012017 cites W3190521604 @default.
- W4283012017 cites W3199387848 @default.
- W4283012017 cites W3201651407 @default.
- W4283012017 cites W3215261291 @default.
- W4283012017 cites W4255489070 @default.
- W4283012017 cites W658807863 @default.
- W4283012017 doi "https://doi.org/10.3389/fimmu.2022.896242" @default.
- W4283012017 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35784320" @default.
- W4283012017 hasPublicationYear "2022" @default.
- W4283012017 type Work @default.
- W4283012017 citedByCount "4" @default.
- W4283012017 countsByYear W42830120172022 @default.
- W4283012017 countsByYear W42830120172023 @default.
- W4283012017 crossrefType "journal-article" @default.
- W4283012017 hasAuthorship W4283012017A5008579041 @default.
- W4283012017 hasAuthorship W4283012017A5016740410 @default.
- W4283012017 hasAuthorship W4283012017A5019440530 @default.
- W4283012017 hasAuthorship W4283012017A5020405049 @default.
- W4283012017 hasAuthorship W4283012017A5021835847 @default.
- W4283012017 hasAuthorship W4283012017A5033369669 @default.
- W4283012017 hasAuthorship W4283012017A5033991846 @default.
- W4283012017 hasAuthorship W4283012017A5035328333 @default.
- W4283012017 hasAuthorship W4283012017A5056333353 @default.